nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—ALB—Vandetanib—thyroid cancer	0.174	0.264	CbGbCtD
Fosphenytoin—CYP2B6—Sorafenib—thyroid cancer	0.107	0.162	CbGbCtD
Fosphenytoin—CYP2C8—Sorafenib—thyroid cancer	0.0811	0.123	CbGbCtD
Fosphenytoin—CYP2C19—Sorafenib—thyroid cancer	0.0681	0.103	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—thyroid cancer	0.065	0.0985	CbGbCtD
Fosphenytoin—CYP2C9—Sorafenib—thyroid cancer	0.0566	0.0858	CbGbCtD
Fosphenytoin—CYP3A4—Vandetanib—thyroid cancer	0.0546	0.0828	CbGbCtD
Fosphenytoin—CYP3A4—Sorafenib—thyroid cancer	0.0329	0.0499	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—thyroid cancer	0.02	0.0303	CbGbCtD
Fosphenytoin—Skin discolouration—Doxorubicin—thyroid cancer	0.000701	0.00206	CcSEcCtD
Fosphenytoin—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.000701	0.00206	CcSEcCtD
Fosphenytoin—Hypertension—Sorafenib—thyroid cancer	0.000698	0.00205	CcSEcCtD
Fosphenytoin—Coordination abnormal—Epirubicin—thyroid cancer	0.000697	0.00205	CcSEcCtD
Fosphenytoin—Pruritus—Vandetanib—thyroid cancer	0.000693	0.00204	CcSEcCtD
Fosphenytoin—Cough increased—Doxorubicin—thyroid cancer	0.000691	0.00203	CcSEcCtD
Fosphenytoin—Thinking abnormal—Doxorubicin—thyroid cancer	0.000691	0.00203	CcSEcCtD
Fosphenytoin—Arthralgia—Sorafenib—thyroid cancer	0.000689	0.00202	CcSEcCtD
Fosphenytoin—Myalgia—Sorafenib—thyroid cancer	0.000689	0.00202	CcSEcCtD
Fosphenytoin—Oliguria—Doxorubicin—thyroid cancer	0.000687	0.00202	CcSEcCtD
Fosphenytoin—Pulmonary embolism—Epirubicin—thyroid cancer	0.000684	0.00201	CcSEcCtD
Fosphenytoin—Vaginal inflammation—Epirubicin—thyroid cancer	0.000684	0.00201	CcSEcCtD
Fosphenytoin—Injection site reaction—Epirubicin—thyroid cancer	0.00068	0.002	CcSEcCtD
Fosphenytoin—Dermatitis contact—Epirubicin—thyroid cancer	0.000676	0.00199	CcSEcCtD
Fosphenytoin—Dry mouth—Sorafenib—thyroid cancer	0.000674	0.00198	CcSEcCtD
Fosphenytoin—Dyskinesia—Doxorubicin—thyroid cancer	0.000673	0.00198	CcSEcCtD
Fosphenytoin—Hyperkalaemia—Epirubicin—thyroid cancer	0.000672	0.00197	CcSEcCtD
Fosphenytoin—Diarrhoea—Vandetanib—thyroid cancer	0.00067	0.00197	CcSEcCtD
Fosphenytoin—Dysarthria—Doxorubicin—thyroid cancer	0.000669	0.00197	CcSEcCtD
Fosphenytoin—Salivary hypersecretion—Epirubicin—thyroid cancer	0.000664	0.00195	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00066	0.00194	CcSEcCtD
Fosphenytoin—Infection—Sorafenib—thyroid cancer	0.000656	0.00193	CcSEcCtD
Fosphenytoin—Shock—Sorafenib—thyroid cancer	0.00065	0.00191	CcSEcCtD
Fosphenytoin—Fluid retention—Epirubicin—thyroid cancer	0.000649	0.00191	CcSEcCtD
Fosphenytoin—Dizziness—Vandetanib—thyroid cancer	0.000647	0.0019	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000646	0.0019	CcSEcCtD
Fosphenytoin—Vaginal infection—Epirubicin—thyroid cancer	0.000646	0.0019	CcSEcCtD
Fosphenytoin—Coordination abnormal—Doxorubicin—thyroid cancer	0.000644	0.00189	CcSEcCtD
Fosphenytoin—Pulmonary embolism—Doxorubicin—thyroid cancer	0.000633	0.00186	CcSEcCtD
Fosphenytoin—Vaginal inflammation—Doxorubicin—thyroid cancer	0.000633	0.00186	CcSEcCtD
Fosphenytoin—Anorexia—Sorafenib—thyroid cancer	0.000629	0.00185	CcSEcCtD
Fosphenytoin—Injection site reaction—Doxorubicin—thyroid cancer	0.000629	0.00185	CcSEcCtD
Fosphenytoin—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000628	0.00185	CcSEcCtD
Fosphenytoin—Dermatitis contact—Doxorubicin—thyroid cancer	0.000625	0.00184	CcSEcCtD
Fosphenytoin—Coma—Epirubicin—thyroid cancer	0.000625	0.00184	CcSEcCtD
Fosphenytoin—Vomiting—Vandetanib—thyroid cancer	0.000622	0.00183	CcSEcCtD
Fosphenytoin—Hyperkalaemia—Doxorubicin—thyroid cancer	0.000622	0.00183	CcSEcCtD
Fosphenytoin—Rash maculo-papular—Epirubicin—thyroid cancer	0.000622	0.00183	CcSEcCtD
Fosphenytoin—Ecchymosis—Epirubicin—thyroid cancer	0.000618	0.00182	CcSEcCtD
Fosphenytoin—Rash—Vandetanib—thyroid cancer	0.000617	0.00181	CcSEcCtD
Fosphenytoin—Dermatitis—Vandetanib—thyroid cancer	0.000617	0.00181	CcSEcCtD
Fosphenytoin—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000615	0.00181	CcSEcCtD
Fosphenytoin—Headache—Vandetanib—thyroid cancer	0.000613	0.0018	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000602	0.00177	CcSEcCtD
Fosphenytoin—Fluid retention—Doxorubicin—thyroid cancer	0.000601	0.00177	CcSEcCtD
Fosphenytoin—Vaginal infection—Doxorubicin—thyroid cancer	0.000597	0.00176	CcSEcCtD
Fosphenytoin—Mental disability—Epirubicin—thyroid cancer	0.000594	0.00174	CcSEcCtD
Fosphenytoin—Sepsis—Epirubicin—thyroid cancer	0.000594	0.00174	CcSEcCtD
Fosphenytoin—Dyspnoea—Sorafenib—thyroid cancer	0.000589	0.00173	CcSEcCtD
Fosphenytoin—Lymphadenopathy—Epirubicin—thyroid cancer	0.000582	0.00171	CcSEcCtD
Fosphenytoin—Nausea—Vandetanib—thyroid cancer	0.000581	0.00171	CcSEcCtD
Fosphenytoin—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000581	0.00171	CcSEcCtD
Fosphenytoin—Dyspepsia—Sorafenib—thyroid cancer	0.000581	0.00171	CcSEcCtD
Fosphenytoin—Coma—Doxorubicin—thyroid cancer	0.000578	0.0017	CcSEcCtD
Fosphenytoin—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000575	0.00169	CcSEcCtD
Fosphenytoin—Decreased appetite—Sorafenib—thyroid cancer	0.000574	0.00169	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Epirubicin—thyroid cancer	0.000574	0.00169	CcSEcCtD
Fosphenytoin—Ecchymosis—Doxorubicin—thyroid cancer	0.000572	0.00168	CcSEcCtD
Fosphenytoin—Constipation—Sorafenib—thyroid cancer	0.000565	0.00166	CcSEcCtD
Fosphenytoin—Eye pain—Epirubicin—thyroid cancer	0.00055	0.00162	CcSEcCtD
Fosphenytoin—Mental disability—Doxorubicin—thyroid cancer	0.000549	0.00161	CcSEcCtD
Fosphenytoin—Sepsis—Doxorubicin—thyroid cancer	0.000549	0.00161	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000547	0.00161	CcSEcCtD
Fosphenytoin—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000538	0.00158	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000531	0.00156	CcSEcCtD
Fosphenytoin—Urticaria—Sorafenib—thyroid cancer	0.000525	0.00154	CcSEcCtD
Fosphenytoin—Body temperature increased—Sorafenib—thyroid cancer	0.000522	0.00153	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000513	0.00151	CcSEcCtD
Fosphenytoin—Eye pain—Doxorubicin—thyroid cancer	0.000509	0.0015	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000507	0.00149	CcSEcCtD
Fosphenytoin—Diplopia—Epirubicin—thyroid cancer	0.000496	0.00146	CcSEcCtD
Fosphenytoin—Osteoarthritis—Epirubicin—thyroid cancer	0.000496	0.00146	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000496	0.00146	CcSEcCtD
Fosphenytoin—Migraine—Epirubicin—thyroid cancer	0.000489	0.00144	CcSEcCtD
Fosphenytoin—Affect lability—Epirubicin—thyroid cancer	0.000489	0.00144	CcSEcCtD
Fosphenytoin—Face oedema—Epirubicin—thyroid cancer	0.000479	0.00141	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000475	0.00139	CcSEcCtD
Fosphenytoin—Asthenia—Sorafenib—thyroid cancer	0.000474	0.00139	CcSEcCtD
Fosphenytoin—Cardiac arrest—Epirubicin—thyroid cancer	0.000472	0.00139	CcSEcCtD
Fosphenytoin—Mood swings—Epirubicin—thyroid cancer	0.00047	0.00138	CcSEcCtD
Fosphenytoin—Pruritus—Sorafenib—thyroid cancer	0.000467	0.00137	CcSEcCtD
Fosphenytoin—Ataxia—Epirubicin—thyroid cancer	0.000467	0.00137	CcSEcCtD
Fosphenytoin—Dehydration—Epirubicin—thyroid cancer	0.000462	0.00136	CcSEcCtD
Fosphenytoin—Diplopia—Doxorubicin—thyroid cancer	0.000459	0.00135	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000459	0.00135	CcSEcCtD
Fosphenytoin—Osteoarthritis—Doxorubicin—thyroid cancer	0.000459	0.00135	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Epirubicin—thyroid cancer	0.000458	0.00135	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000453	0.00133	CcSEcCtD
Fosphenytoin—Affect lability—Doxorubicin—thyroid cancer	0.000452	0.00133	CcSEcCtD
Fosphenytoin—Migraine—Doxorubicin—thyroid cancer	0.000452	0.00133	CcSEcCtD
Fosphenytoin—Hypokalaemia—Epirubicin—thyroid cancer	0.000452	0.00133	CcSEcCtD
Fosphenytoin—Diarrhoea—Sorafenib—thyroid cancer	0.000452	0.00133	CcSEcCtD
Fosphenytoin—Face oedema—Doxorubicin—thyroid cancer	0.000443	0.0013	CcSEcCtD
Fosphenytoin—Gastritis—Epirubicin—thyroid cancer	0.000439	0.00129	CcSEcCtD
Fosphenytoin—Muscular weakness—Epirubicin—thyroid cancer	0.000438	0.00129	CcSEcCtD
Fosphenytoin—Cardiac arrest—Doxorubicin—thyroid cancer	0.000437	0.00128	CcSEcCtD
Fosphenytoin—Dizziness—Sorafenib—thyroid cancer	0.000437	0.00128	CcSEcCtD
Fosphenytoin—Mood swings—Doxorubicin—thyroid cancer	0.000435	0.00128	CcSEcCtD
Fosphenytoin—Ataxia—Doxorubicin—thyroid cancer	0.000432	0.00127	CcSEcCtD
Fosphenytoin—Dysphagia—Epirubicin—thyroid cancer	0.000429	0.00126	CcSEcCtD
Fosphenytoin—Influenza—Epirubicin—thyroid cancer	0.000429	0.00126	CcSEcCtD
Fosphenytoin—Asthma—Epirubicin—thyroid cancer	0.000429	0.00126	CcSEcCtD
Fosphenytoin—Dehydration—Doxorubicin—thyroid cancer	0.000427	0.00126	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000424	0.00125	CcSEcCtD
Fosphenytoin—Vomiting—Sorafenib—thyroid cancer	0.00042	0.00123	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00042	0.00123	CcSEcCtD
Fosphenytoin—Hypokalaemia—Doxorubicin—thyroid cancer	0.000418	0.00123	CcSEcCtD
Fosphenytoin—Rash—Sorafenib—thyroid cancer	0.000416	0.00122	CcSEcCtD
Fosphenytoin—Dermatitis—Sorafenib—thyroid cancer	0.000416	0.00122	CcSEcCtD
Fosphenytoin—Headache—Sorafenib—thyroid cancer	0.000414	0.00122	CcSEcCtD
Fosphenytoin—Bronchitis—Epirubicin—thyroid cancer	0.000413	0.00121	CcSEcCtD
Fosphenytoin—Gastritis—Doxorubicin—thyroid cancer	0.000407	0.00119	CcSEcCtD
Fosphenytoin—Muscular weakness—Doxorubicin—thyroid cancer	0.000405	0.00119	CcSEcCtD
Fosphenytoin—Dysuria—Epirubicin—thyroid cancer	0.000401	0.00118	CcSEcCtD
Fosphenytoin—Asthma—Doxorubicin—thyroid cancer	0.000397	0.00117	CcSEcCtD
Fosphenytoin—Dysphagia—Doxorubicin—thyroid cancer	0.000397	0.00117	CcSEcCtD
Fosphenytoin—Influenza—Doxorubicin—thyroid cancer	0.000397	0.00117	CcSEcCtD
Fosphenytoin—Nausea—Sorafenib—thyroid cancer	0.000392	0.00115	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000392	0.00115	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Epirubicin—thyroid cancer	0.000387	0.00114	CcSEcCtD
Fosphenytoin—Pneumonia—Epirubicin—thyroid cancer	0.000385	0.00113	CcSEcCtD
Fosphenytoin—Bronchitis—Doxorubicin—thyroid cancer	0.000382	0.00112	CcSEcCtD
Fosphenytoin—Renal failure—Epirubicin—thyroid cancer	0.000376	0.00111	CcSEcCtD
Fosphenytoin—Conjunctivitis—Epirubicin—thyroid cancer	0.000372	0.00109	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—thyroid cancer	0.000371	0.00109	CcSEcCtD
Fosphenytoin—Sweating—Epirubicin—thyroid cancer	0.000367	0.00108	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000362	0.00107	CcSEcCtD
Fosphenytoin—Epistaxis—Epirubicin—thyroid cancer	0.000361	0.00106	CcSEcCtD
Fosphenytoin—Sinusitis—Epirubicin—thyroid cancer	0.000359	0.00105	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000358	0.00105	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—thyroid cancer	0.000356	0.00105	CcSEcCtD
Fosphenytoin—Bradycardia—Epirubicin—thyroid cancer	0.00035	0.00103	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—thyroid cancer	0.000348	0.00102	CcSEcCtD
Fosphenytoin—Rhinitis—Epirubicin—thyroid cancer	0.000344	0.00101	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—thyroid cancer	0.000344	0.00101	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000342	0.001	CcSEcCtD
Fosphenytoin—Pharyngitis—Epirubicin—thyroid cancer	0.000341	0.001	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—thyroid cancer	0.000339	0.000997	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—thyroid cancer	0.000334	0.000981	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—thyroid cancer	0.000332	0.000976	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—thyroid cancer	0.000324	0.000951	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—thyroid cancer	0.00032	0.000941	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—thyroid cancer	0.000319	0.000936	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000316	0.000929	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—thyroid cancer	0.000315	0.000927	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—thyroid cancer	0.000308	0.000906	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—thyroid cancer	0.000296	0.000871	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—thyroid cancer	0.000295	0.000866	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—thyroid cancer	0.000293	0.000862	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—thyroid cancer	0.000293	0.00086	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—thyroid cancer	0.00029	0.000853	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—thyroid cancer	0.000289	0.00085	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—thyroid cancer	0.000287	0.000845	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—thyroid cancer	0.000285	0.000838	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000277	0.000815	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—thyroid cancer	0.000276	0.000812	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—thyroid cancer	0.000275	0.000807	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—thyroid cancer	0.000273	0.000801	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—thyroid cancer	0.000271	0.000798	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—thyroid cancer	0.000271	0.000796	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—thyroid cancer	0.00027	0.000792	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—thyroid cancer	0.000269	0.00079	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—thyroid cancer	0.000269	0.000789	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—thyroid cancer	0.000268	0.000788	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—thyroid cancer	0.000268	0.000786	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—thyroid cancer	0.000268	0.000786	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—thyroid cancer	0.000266	0.000782	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—thyroid cancer	0.000264	0.000776	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—thyroid cancer	0.000263	0.000772	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—thyroid cancer	0.000261	0.000767	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—thyroid cancer	0.000259	0.000761	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—thyroid cancer	0.000258	0.000759	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000257	0.000754	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—thyroid cancer	0.000256	0.000751	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—thyroid cancer	0.000255	0.000748	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—thyroid cancer	0.000255	0.000748	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—thyroid cancer	0.000254	0.000747	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—thyroid cancer	0.000252	0.000739	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—thyroid cancer	0.000249	0.000733	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—thyroid cancer	0.000249	0.000732	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—thyroid cancer	0.000249	0.00073	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—thyroid cancer	0.000248	0.000729	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—thyroid cancer	0.000248	0.000728	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—thyroid cancer	0.000246	0.000723	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—thyroid cancer	0.000244	0.000718	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000244	0.000717	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000243	0.000715	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—thyroid cancer	0.000242	0.000712	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—thyroid cancer	0.000241	0.000709	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—thyroid cancer	0.00024	0.000705	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—thyroid cancer	0.00024	0.000704	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000239	0.000702	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—thyroid cancer	0.000239	0.000702	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—thyroid cancer	0.000238	0.0007	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000236	0.000693	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—thyroid cancer	0.000236	0.000692	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—thyroid cancer	0.000236	0.000692	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—thyroid cancer	0.000233	0.000684	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—thyroid cancer	0.000233	0.000684	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—thyroid cancer	0.00023	0.000677	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—thyroid cancer	0.000228	0.00067	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—thyroid cancer	0.000228	0.000669	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000226	0.000664	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—thyroid cancer	0.000224	0.000659	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000222	0.000653	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—thyroid cancer	0.000222	0.000653	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000221	0.00065	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—thyroid cancer	0.000221	0.000649	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—thyroid cancer	0.00022	0.000648	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—thyroid cancer	0.000219	0.000644	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000218	0.000641	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—thyroid cancer	0.000218	0.000639	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—thyroid cancer	0.000217	0.000637	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—thyroid cancer	0.000215	0.000632	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—thyroid cancer	0.000215	0.000631	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—thyroid cancer	0.000212	0.000623	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—thyroid cancer	0.000211	0.00062	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—thyroid cancer	0.000209	0.000613	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000206	0.000605	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—thyroid cancer	0.000204	0.0006	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—thyroid cancer	0.000203	0.000596	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—thyroid cancer	0.000201	0.000592	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—thyroid cancer	0.000201	0.000591	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—thyroid cancer	0.000201	0.00059	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—thyroid cancer	0.000199	0.000584	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—thyroid cancer	0.000196	0.000577	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—thyroid cancer	0.000194	0.00057	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—thyroid cancer	0.000193	0.000567	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—thyroid cancer	0.000193	0.000567	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000186	0.000547	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—thyroid cancer	0.000179	0.000527	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—thyroid cancer	0.000178	0.000525	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—thyroid cancer	0.000175	0.000514	CcSEcCtD
Fosphenytoin—Pruritus—Epirubicin—thyroid cancer	0.000173	0.000507	CcSEcCtD
Fosphenytoin—Diarrhoea—Epirubicin—thyroid cancer	0.000167	0.000491	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—thyroid cancer	0.000162	0.000476	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—thyroid cancer	0.000161	0.000474	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—thyroid cancer	0.00016	0.000469	CcSEcCtD
Fosphenytoin—Vomiting—Epirubicin—thyroid cancer	0.000155	0.000456	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—thyroid cancer	0.000154	0.000454	CcSEcCtD
Fosphenytoin—Rash—Epirubicin—thyroid cancer	0.000154	0.000452	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—thyroid cancer	0.000154	0.000452	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—thyroid cancer	0.000153	0.000449	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—thyroid cancer	0.000149	0.000439	CcSEcCtD
Fosphenytoin—Nausea—Epirubicin—thyroid cancer	0.000145	0.000426	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—thyroid cancer	0.000144	0.000422	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—thyroid cancer	0.000142	0.000418	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—thyroid cancer	0.000142	0.000418	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—thyroid cancer	0.000141	0.000416	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—thyroid cancer	0.000134	0.000394	CcSEcCtD
